ProKidney Corp.
- Joy S. Alex
Joy S. Alex is currently a Central Monitoring Associate at ProKidney Corp. They previously held positions such as Central Monitoring Lead at Syneos Health, Inhouse Monitoring/TMF Specialist at IQVIA, and Heart Research Coordinator at UNC REX Healthcare. With a background as a Senior Clinical Monitoring Associate at PAREXEL and Research Associate/Project Manager at University of Rochester Medical Center, Joy S. Alex brings a wealth of experience to their current role. Their education includes attending Alfred State College - SUNY College of Technology, Drexel University College of Medicine, SUNY Empire State College, and University of Rochester School of Medicine and Dentistry.
Org chart
Upgrade to view 0 reports
Offices
This person is not in any offices
ProKidney Corp.
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function. Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022. For more information, visit www.prokidney.com.
